Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Passive Immune (NK, LAK etc)
1.2.3 Active Immune
1.3 Market by Application
1.3.1 Global Immuno-Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Oncology
1.3.3 Cardiovascular Disease (CVD)
1.3.4 Orthopedic
1.3.5 Wound Healing
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Cell Therapy Market Perspective (2018-2033)
2.2 Global Immuno-Cell Therapy Growth Trends by Region
2.2.1 Immuno-Cell Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Immuno-Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Immuno-Cell Therapy Forecasted Market Size by Region (2024-2033)
2.3 Immuno-Cell Therapy Market Dynamics
2.3.1 Immuno-Cell Therapy Industry Trends
2.3.2 Immuno-Cell Therapy Market Drivers
2.3.3 Immuno-Cell Therapy Market Challenges
2.3.4 Immuno-Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Immuno-Cell Therapy by Players
3.1.1 Global Immuno-Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global Immuno-Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immuno-Cell Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Immuno-Cell Therapy Market Concentration Ratio
3.4.1 Global Immuno-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Cell Therapy Revenue in 2022
3.5 Global Key Players of Immuno-Cell Therapy Head office and Area Served
3.6 Global Key Players of Immuno-Cell Therapy, Product and Application
3.7 Global Key Players of Immuno-Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Cell Therapy Breakdown Data by Type
4.1 Global Immuno-Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Immuno-Cell Therapy Forecasted Market Size by Type (2024-2033)
5 Immuno-Cell Therapy Breakdown Data by Application
5.1 Global Immuno-Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Immuno-Cell Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immuno-Cell Therapy Market Size (2018-2033)
6.2 North America Immuno-Cell Therapy Market Size by Type
6.2.1 North America Immuno-Cell Therapy Market Size by Type (2018-2023)
6.2.2 North America Immuno-Cell Therapy Market Size by Type (2024-2033)
6.2.3 North America Immuno-Cell Therapy Market Share by Type (2018-2033)
6.3 North America Immuno-Cell Therapy Market Size by Application
6.3.1 North America Immuno-Cell Therapy Market Size by Application (2018-2023)
6.3.2 North America Immuno-Cell Therapy Market Size by Application (2024-2033)
6.3.3 North America Immuno-Cell Therapy Market Share by Application (2018-2033)
6.4 North America Immuno-Cell Therapy Market Size by Country
6.4.1 North America Immuno-Cell Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Immuno-Cell Therapy Market Size by Country (2018-2023)
6.4.3 North America Immuno-Cell Therapy Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Immuno-Cell Therapy Market Size (2018-2033)
7.2 Europe Immuno-Cell Therapy Market Size by Type
7.2.1 Europe Immuno-Cell Therapy Market Size by Type (2018-2023)
7.2.2 Europe Immuno-Cell Therapy Market Size by Type (2024-2033)
7.2.3 Europe Immuno-Cell Therapy Market Share by Type (2018-2033)
7.3 Europe Immuno-Cell Therapy Market Size by Application
7.3.1 Europe Immuno-Cell Therapy Market Size by Application (2018-2023)
7.3.2 Europe Immuno-Cell Therapy Market Size by Application (2024-2033)
7.3.3 Europe Immuno-Cell Therapy Market Share by Application (2018-2033)
7.4 Europe Immuno-Cell Therapy Market Size by Country
7.4.1 Europe Immuno-Cell Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Immuno-Cell Therapy Market Size by Country (2018-2023)
7.4.3 Europe Immuno-Cell Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Immuno-Cell Therapy Market Size (2018-2033)
8.2 China Immuno-Cell Therapy Market Size by Type
8.2.1 China Immuno-Cell Therapy Market Size by Type (2018-2023)
8.2.2 China Immuno-Cell Therapy Market Size by Type (2024-2033)
8.2.3 China Immuno-Cell Therapy Market Share by Type (2018-2033)
8.3 China Immuno-Cell Therapy Market Size by Application
8.3.1 China Immuno-Cell Therapy Market Size by Application (2018-2023)
8.3.2 China Immuno-Cell Therapy Market Size by Application (2024-2033)
8.3.3 China Immuno-Cell Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Immuno-Cell Therapy Market Size (2018-2033)
9.2 Asia Immuno-Cell Therapy Market Size by Type
9.2.1 Asia Immuno-Cell Therapy Market Size by Type (2018-2023)
9.2.2 Asia Immuno-Cell Therapy Market Size by Type (2024-2033)
9.2.3 Asia Immuno-Cell Therapy Market Share by Type (2018-2033)
9.3 Asia Immuno-Cell Therapy Market Size by Application
9.3.1 Asia Immuno-Cell Therapy Market Size by Application (2018-2023)
9.3.2 Asia Immuno-Cell Therapy Market Size by Application (2024-2033)
9.3.3 Asia Immuno-Cell Therapy Market Share by Application (2018-2033)
9.4 Asia Immuno-Cell Therapy Market Size by Region
9.4.1 Asia Immuno-Cell Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Immuno-Cell Therapy Market Size by Region (2018-2023)
9.4.3 Asia Immuno-Cell Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 MEDINET Co
11.1.1 MEDINET Co Company Details
11.1.2 MEDINET Co Business Overview
11.1.3 MEDINET Co Immuno-Cell Therapy Introduction
11.1.4 MEDINET Co Revenue in Immuno-Cell Therapy Business (2018-2023)
11.1.5 MEDINET Co Recent Developments
11.2 Erytech
11.2.1 Erytech Company Details
11.2.2 Erytech Business Overview
11.2.3 Erytech Immuno-Cell Therapy Introduction
11.2.4 Erytech Revenue in Immuno-Cell Therapy Business (2018-2023)
11.2.5 Erytech Recent Developments
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Details
11.3.2 Seta Clinic Group Business Overview
11.3.3 Seta Clinic Group Immuno-Cell Therapy Introduction
11.3.4 Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2018-2023)
11.3.5 Seta Clinic Group Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Immuno-Cell Therapy Introduction
11.4.4 Takeda Revenue in Immuno-Cell Therapy Business (2018-2023)
11.4.5 Takeda Recent Developments
11.5 SBI Holdings
11.5.1 SBI Holdings Company Details
11.5.2 SBI Holdings Business Overview
11.5.3 SBI Holdings Immuno-Cell Therapy Introduction
11.5.4 SBI Holdings Revenue in Immuno-Cell Therapy Business (2018-2023)
11.5.5 SBI Holdings Recent Developments
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Details
11.6.2 Oxford BioTherapeutics Business Overview
11.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Introduction
11.6.4 Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2018-2023)
11.6.5 Oxford BioTherapeutics Recent Developments
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Details
11.7.2 Fate Therapeutics Business Overview
11.7.3 Fate Therapeutics Immuno-Cell Therapy Introduction
11.7.4 Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2018-2023)
11.7.5 Fate Therapeutics Recent Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Immuno-Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Immuno-Cell Therapy Business (2018-2023)
11.8.5 Gilead Sciences Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Cell Therapy Introduction
11.9.4 Novartis Revenue in Immuno-Cell Therapy Business (2018-2023)
11.9.5 Novartis Recent Developments
11.10 Osiris
11.10.1 Osiris Company Details
11.10.2 Osiris Business Overview
11.10.3 Osiris Immuno-Cell Therapy Introduction
11.10.4 Osiris Revenue in Immuno-Cell Therapy Business (2018-2023)
11.10.5 Osiris Recent Developments
11.11 Vericel Corporation
11.11.1 Vericel Corporation Company Details
11.11.2 Vericel Corporation Business Overview
11.11.3 Vericel Corporation Immuno-Cell Therapy Introduction
11.11.4 Vericel Corporation Revenue in Immuno-Cell Therapy Business (2018-2023)
11.11.5 Vericel Corporation Recent Developments
11.12 Fujifilm Cellular Dynamics
11.12.1 Fujifilm Cellular Dynamics Company Details
11.12.2 Fujifilm Cellular Dynamics Business Overview
11.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Introduction
11.12.4 Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2018-2023)
11.12.5 Fujifilm Cellular Dynamics Recent Developments
11.13 JCR Pharmaceuticals
11.13.1 JCR Pharmaceuticals Company Details
11.13.2 JCR Pharmaceuticals Business Overview
11.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Introduction
11.13.4 JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2018-2023)
11.13.5 JCR Pharmaceuticals Recent Developments
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Details
11.14.2 Beike Biotechnology Business Overview
11.14.3 Beike Biotechnology Immuno-Cell Therapy Introduction
11.14.4 Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2018-2023)
11.14.5 Beike Biotechnology Recent Developments
11.15 Golden Meditech
11.15.1 Golden Meditech Company Details
11.15.2 Golden Meditech Business Overview
11.15.3 Golden Meditech Immuno-Cell Therapy Introduction
11.15.4 Golden Meditech Revenue in Immuno-Cell Therapy Business (2018-2023)
11.15.5 Golden Meditech Recent Developments
11.16 Guanhao Biotech
11.16.1 Guanhao Biotech Company Details
11.16.2 Guanhao Biotech Business Overview
11.16.3 Guanhao Biotech Immuno-Cell Therapy Introduction
11.16.4 Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2018-2023)
11.16.5 Guanhao Biotech Recent Developments
11.17 Beroni Group
11.17.1 Beroni Group Company Details
11.17.2 Beroni Group Business Overview
11.17.3 Beroni Group Immuno-Cell Therapy Introduction
11.17.4 Beroni Group Revenue in Immuno-Cell Therapy Business (2018-2023)
11.17.5 Beroni Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immuno-Cell Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Passive Immune (NK, LAK etc)
Table 3. Key Players of Active Immune
Table 4. Global Immuno-Cell Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Immuno-Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Immuno-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Immuno-Cell Therapy Market Share by Region (2018-2023)
Table 8. Global Immuno-Cell Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Immuno-Cell Therapy Market Share by Region (2024-2033)
Table 10. Immuno-Cell Therapy Market Trends
Table 11. Immuno-Cell Therapy Market Drivers
Table 12. Immuno-Cell Therapy Market Challenges
Table 13. Immuno-Cell Therapy Market Restraints
Table 14. Global Immuno-Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Immuno-Cell Therapy Revenue Share by Players (2018-2023)
Table 16. Global Top Immuno-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Cell Therapy as of 2022)
Table 17. Global Immuno-Cell Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Immuno-Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Immuno-Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Immuno-Cell Therapy, Product and Application
Table 21. Global Key Players of Immuno-Cell Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Immuno-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Immuno-Cell Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Immuno-Cell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Immuno-Cell Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Immuno-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Immuno-Cell Therapy Revenue Share by Application (2018-2023)
Table 29. Global Immuno-Cell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Immuno-Cell Therapy Revenue Share by Application (2024-2033)
Table 31. North America Immuno-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Immuno-Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Immuno-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Immuno-Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Immuno-Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Immuno-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Immuno-Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Immuno-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Immuno-Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Immuno-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Immuno-Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Immuno-Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Immuno-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Immuno-Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Immuno-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Immuno-Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Immuno-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Immuno-Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Immuno-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Immuno-Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Immuno-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Immuno-Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Immuno-Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Immuno-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Immuno-Cell Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Immuno-Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 63. MEDINET Co Company Details
Table 64. MEDINET Co Business Overview
Table 65. MEDINET Co Immuno-Cell Therapy Product
Table 66. MEDINET Co Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 67. MEDINET Co Recent Developments
Table 68. Erytech Company Details
Table 69. Erytech Business Overview
Table 70. Erytech Immuno-Cell Therapy Product
Table 71. Erytech Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 72. Erytech Recent Developments
Table 73. Seta Clinic Group Company Details
Table 74. Seta Clinic Group Business Overview
Table 75. Seta Clinic Group Immuno-Cell Therapy Product
Table 76. Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 77. Seta Clinic Group Recent Developments
Table 78. Takeda Company Details
Table 79. Takeda Business Overview
Table 80. Takeda Immuno-Cell Therapy Product
Table 81. Takeda Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 82. Takeda Recent Developments
Table 83. SBI Holdings Company Details
Table 84. SBI Holdings Business Overview
Table 85. SBI Holdings Immuno-Cell Therapy Product
Table 86. SBI Holdings Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 87. SBI Holdings Recent Developments
Table 88. Oxford BioTherapeutics Company Details
Table 89. Oxford BioTherapeutics Business Overview
Table 90. Oxford BioTherapeutics Immuno-Cell Therapy Product
Table 91. Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 92. Oxford BioTherapeutics Recent Developments
Table 93. Fate Therapeutics Company Details
Table 94. Fate Therapeutics Business Overview
Table 95. Fate Therapeutics Immuno-Cell Therapy Product
Table 96. Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 97. Fate Therapeutics Recent Developments
Table 98. Gilead Sciences Company Details
Table 99. Gilead Sciences Business Overview
Table 100. Gilead Sciences Immuno-Cell Therapy Product
Table 101. Gilead Sciences Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 102. Gilead Sciences Recent Developments
Table 103. Novartis Company Details
Table 104. Novartis Business Overview
Table 105. Novartis Immuno-Cell Therapy Product
Table 106. Novartis Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 107. Novartis Recent Developments
Table 108. Osiris Company Details
Table 109. Osiris Business Overview
Table 110. Osiris Immuno-Cell Therapy Product
Table 111. Osiris Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 112. Osiris Recent Developments
Table 113. Vericel Corporation Company Details
Table 114. Vericel Corporation Business Overview
Table 115. Vericel Corporation Immuno-Cell Therapy Product
Table 116. Vericel Corporation Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 117. Vericel Corporation Recent Developments
Table 118. Fujifilm Cellular Dynamics Company Details
Table 119. Fujifilm Cellular Dynamics Business Overview
Table 120. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product
Table 121. Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 122. Fujifilm Cellular Dynamics Recent Developments
Table 123. JCR Pharmaceuticals Company Details
Table 124. JCR Pharmaceuticals Business Overview
Table 125. JCR Pharmaceuticals Immuno-Cell Therapy Product
Table 126. JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 127. JCR Pharmaceuticals Recent Developments
Table 128. Beike Biotechnology Company Details
Table 129. Beike Biotechnology Business Overview
Table 130. Beike Biotechnology Immuno-Cell Therapy Product
Table 131. Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 132. Beike Biotechnology Recent Developments
Table 133. Golden Meditech Company Details
Table 134. Golden Meditech Business Overview
Table 135. Golden Meditech Immuno-Cell Therapy Product
Table 136. Golden Meditech Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 137. Golden Meditech Recent Developments
Table 138. Guanhao Biotech Company Details
Table 139. Guanhao Biotech Business Overview
Table 140. Guanhao Biotech Immuno-Cell Therapy Product
Table 141. Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 142. Guanhao Biotech Recent Developments
Table 143. Beroni Group Company Details
Table 144. Beroni Group Business Overview
Table 145. Beroni Group Immuno-Cell Therapy Product
Table 146. Beroni Group Revenue in Immuno-Cell Therapy Business (2018-2023) & (US$ Million)
Table 147. Beroni Group Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Immuno-Cell Therapy Market Share by Type: 2022 VS 2033
Figure 3. Passive Immune (NK, LAK etc) Features
Figure 4. Active Immune Features
Figure 5. Global Immuno-Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Immuno-Cell Therapy Market Share by Application: 2022 VS 2033
Figure 7. Oncology Case Studies
Figure 8. Cardiovascular Disease (CVD) Case Studies
Figure 9. Orthopedic Case Studies
Figure 10. Wound Healing Case Studies
Figure 11. Others Case Studies
Figure 12. Immuno-Cell Therapy Report Years Considered
Figure 13. Global Immuno-Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Immuno-Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Immuno-Cell Therapy Market Share by Region: 2022 VS 2033
Figure 16. Global Immuno-Cell Therapy Market Share by Players in 2022
Figure 17. Global Top Immuno-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Cell Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Immuno-Cell Therapy Revenue in 2022
Figure 19. North America Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Immuno-Cell Therapy Market Share by Type (2018-2033)
Figure 21. North America Immuno-Cell Therapy Market Share by Application (2018-2033)
Figure 22. North America Immuno-Cell Therapy Market Share by Country (2018-2033)
Figure 23. United States Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Immuno-Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Immuno-Cell Therapy Market Share by Type (2018-2033)
Figure 27. Europe Immuno-Cell Therapy Market Share by Application (2018-2033)
Figure 28. Europe Immuno-Cell Therapy Market Share by Country (2018-2033)
Figure 29. Germany Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Immuno-Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Immuno-Cell Therapy Market Share by Type (2018-2033)
Figure 37. China Immuno-Cell Therapy Market Share by Application (2018-2033)
Figure 38. Asia Immuno-Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Immuno-Cell Therapy Market Share by Type (2018-2033)
Figure 40. Asia Immuno-Cell Therapy Market Share by Application (2018-2033)
Figure 41. Asia Immuno-Cell Therapy Market Share by Region (2018-2033)
Figure 42. Japan Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Immuno-Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Immuno-Cell Therapy Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Immuno-Cell Therapy Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Immuno-Cell Therapy Market Share by Country (2018-2033)
Figure 52. Brazil Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Immuno-Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. MEDINET Co Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 59. Erytech Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 60. Seta Clinic Group Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 61. Takeda Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 62. SBI Holdings Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 63. Oxford BioTherapeutics Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 64. Fate Therapeutics Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 65. Gilead Sciences Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 66. Novartis Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 67. Osiris Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 68. Vericel Corporation Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 69. Fujifilm Cellular Dynamics Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 70. JCR Pharmaceuticals Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 71. Beike Biotechnology Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 72. Golden Meditech Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 73. Guanhao Biotech Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 74. Beroni Group Revenue Growth Rate in Immuno-Cell Therapy Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed